These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17064656)

  • 1. High risk of bacterobilia in advanced experimental chronic fasciolosis.
    Valero MA; Navarro M; Garcia-Bodelon MA; Marcilla A; Morales M; Hernandez JL; Mengual P; Mas-Coma S
    Acta Trop; 2006 Nov; 100(1-2):17-23. PubMed ID: 17064656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaemia in advanced chronic fasciolosis.
    Valero MA; Gironès N; García-Bodelón MA; Periago MV; Chico-Calero I; Khoubbane M; Fresno M; Mas-Coma S
    Acta Trop; 2008 Oct; 108(1):35-43. PubMed ID: 18805388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of gallstone disease in advanced chronic phase of fascioliasis: an experimental study in a rat model.
    Valero MA; Santana M; Morales M; Hernandez JL; Mas-Coma S
    J Infect Dis; 2003 Sep; 188(5):787-93. PubMed ID: 12934197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Route of infection in extrahepatic biliary tract disease. I: Experimental evidence against an entero-hepatico-biliary cycle of bacteria.
    Nielsen ML
    Scand J Gastroenterol Suppl; 1976; 37():11-6. PubMed ID: 818701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human fasciolosis: a study on the relation of infection intensity and treatment to hepatobiliary affection.
    Osman MM; Ismail Y; Aref TY
    J Egypt Soc Parasitol; 1999 Aug; 29(2):353-63. PubMed ID: 10605489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency of urinary tract infection in pediatric liver transplantation candidates.
    Baskin E; Ozçay F; Sakalli H; Agras PI; Karakayali H; Canan O; Haberal M
    Pediatr Transplant; 2007 Jun; 11(4):402-7. PubMed ID: 17493220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serum glucose and beta-hydroxybutyrate levels in sheep with experimental Fasciola hepatica and Fasciola gigantica infection.
    Phiri IK; Phiri AM; Harrison LJ
    Vet Parasitol; 2007 Feb; 143(3-4):287-93. PubMed ID: 17011709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of bacteria and biliary tract diseases.
    Singh Z; Wani NA; Misgar MS; Rashid PA
    Int Surg; 1977 Oct; 62(10):564-5. PubMed ID: 591228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A contribution to the model of biliary infection in rats.
    Martínková J; Rýdlová I; Horák V
    Exp Toxicol Pathol; 1992 Apr; 44(2):102-4. PubMed ID: 1617285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of the liver and biliary tract to anaerobic infection in extrahepatic biliary tract obstruction. II. Liver function and morphology of the liver and biliary tract--an experimental study in rabbits.
    Nielsen ML; Asnaes S; Stage JG
    Scand J Gastroenterol; 1976; 11(1):73-85. PubMed ID: 1251134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial invasion of the biliary system by way of the portal-venous system.
    Sung JY; Shaffer EA; Olson ME; Leung JW; Lam K; Costerton JW
    Hepatology; 1991 Aug; 14(2):313-7. PubMed ID: 1860688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activities of cefoxitin in vitro and in vivo: a study in patients with biliary tract infection undergoing percutaneous transhepatic biliary drainage.
    Masuda G; Tabata I; Isawa T; Yamazaki E; Mizuoka K
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):367-72. PubMed ID: 3526054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between normocytic, hypochromic anaemia and iron concentration together with hepatic enzyme activities in cattle infected with Fasciola hepatica.
    Lotfollahzadeh S; Mohri M; Bahadori ShR; Dezfouly MR; Tajik P
    J Helminthol; 2008 Mar; 82(1):85-8. PubMed ID: 18190732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complex treatment of patients with chronic fascioliasis complicated by bacterial infection of the biliary tract].
    Rakhmanov ER
    Med Parazitol (Mosk); 1987; (2):32-4. PubMed ID: 3600507
    [No Abstract]   [Full Text] [Related]  

  • 15. The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica.
    Keiser J; Utzinger J; Tanner M; Dong Y; Vennerstrom JL
    J Antimicrob Chemother; 2006 Dec; 58(6):1193-7. PubMed ID: 17028093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathological changes of liver in infection of Fasciola hepatica].
    Gajewska A; Smaga-Kozłowska K; Wiśniewski M
    Wiad Parazytol; 2005; 51(2):115-23. PubMed ID: 16838620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and transient cytotoxic response of peritoneal cells from Fasciola hepatica-infected rats.
    Sibille P; Tliba O; Boulard C
    Vet Res; 2004; 35(5):573-84. PubMed ID: 15369660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crowding effect on adult growth, pre-patent period and egg shedding of Fasciola hepatica.
    Valero MA; De Renzi M; Panova M; Garcia-Bodelon MA; Periago MV; Ordoñez D; Mas-Coma S
    Parasitology; 2006 Oct; 133(Pt 4):453-63. PubMed ID: 16817992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bacteriological aspects of biliary tract diseases].
    Ulrich C
    Ned Tijdschr Geneeskd; 1981 Jan; 125(5):187-90. PubMed ID: 7010187
    [No Abstract]   [Full Text] [Related]  

  • 20. The development of biliary infection. An experimental study.
    Kune GA; Hibberd J; Morahan R
    Med J Aust; 1974 Mar; 1(9):301-3. PubMed ID: 4596107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.